Metabolic pathways, genomic alterations, and post-translational modifications in pulmonary hypertension and cancer as therapeutic targets and biomarkers
This study elucidates metabolic and PTM changes in PH and cancer, indicating DHA and EPA's role in reducing oxidative stress and inflammation. These findings support targeting these pathways for early biomarkers and therapies, potentially improving disease management and patient outcomes.
Authors
- Zhiqing Fu (ORCID: https://orcid.org/0000-0003-3699-2673)
- Sheng Li (ORCID: https://orcid.org/0000-0002-4080-7605)
- Haijun Wang (ORCID: https://orcid.org/0000-0002-9236-4842)
- Xiujin Zhang (ORCID: https://orcid.org/0009-0001-9954-1450)
Institutions
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-20
- DOI
- https://doi.org/10.3389/fphar.2024.1490892
- Citations
- 3
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.26